Hospira, Inc, a global specialty pharmaceutical and medication delivery company, announced that the US Food and Drug Administration (FDA) approved a new indication for Precedex (Dexmedetomidine Hydrochloride Injection), the company's innovative drug for in-hospital sedation. This approval allows for use of Precedex in non-intubated patients requiring sedation prior to and/or during surgical and other procedures.
The details can be read here.
No comments:
Post a Comment